Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
05.08.26
/
50%
€21.59
Target price
05.08.27
€39.01
Performance (%)
4.82%
Price
08:33
?
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 4.82%. This prediction currently runs until 05.08.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.82% |
| iShares Core DAX® | 2,57 % |
| iShares Nasdaq 100 | 4,86 % |
| iShares Nikkei 225® | 5,59 % |
| iShares S&P 500 | 3,25 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (RARE) had its price target lowered by Wells Fargo & Company from $47.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€22.06
06.05.26
06.05.26
€40.10
06.05.27
06.05.27
2.58%
08:33
08:33
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€17.00
30.12.25
30.12.25
€38.21
30.12.26
30.12.26
33.12%
08:33
08:33
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€29.20
20.10.25
20.10.25
€55.74
20.10.26
20.10.26
-22.50%
08:33
08:33
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€26.00
10.07.25
10.07.25
€55.35
10.07.26
10.07.26
12.42%
11.07.26
11.07.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.80
20.12.24
20.12.24
€84.54
20.12.25
20.12.25
-32.06%
21.12.25
21.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.20
02.08.24
02.08.24
€68.71
02.08.25
02.08.25
-46.75%
03.08.25
03.08.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.60
08.12.23
08.12.23
€66.97
08.12.24
08.12.24
23.94%
09.12.24
09.12.24